What is the current Price Target for the Atossa Genetics Inc. stock?

The average Atossa Genetics Inc. target price is $5.50. This is 756.03% higher than the current stock price. The highest price target is 989.49%, the lowest is 522.57%. 2 Analysts have issued a price target Atossa Genetics Inc. 2026 .

How high will the Atossa Genetics Inc. stock rise?

No reliable answer can be given as to how high the Atossa Genetics Inc. stock will rise. The performance of stocks, including the Atossa Genetics Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Atossa Genetics Inc. stock today?

The performance of Atossa Genetics Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Atossa Genetics Inc. stock fall?

The decline in Atossa Genetics Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Atossa Genetics Inc. Forecast, price target & analysts

$0.60

6.40% today

Nasdaq, Apr 04, 08:46 pm CET

ISIN

US04962H5063

Symbol

ATOS

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Medical specialties

Overview Dividends Analysts Charts News Strategies

Atossa Genetics Inc. Target price 2025 - Analyst rating & recommendation

Atossa Genetics Inc. Classifications & Recommendation:

Buy

100%

Atossa Genetics Inc. Price Target

Target Price	$5.50
Price	$0.64
Potential	756.03% register free of charge
Number of Estimates	2

	2 Analysts have issued a price target Atossa Genetics Inc. 2026 . The average Atossa Genetics Inc. target price is $5.50. This is 756.03% register free of charge higher than the current stock price. The highest price target is $7.00 989.49% register free of charge , the lowest is $4.00 522.57% register free of charge .
	A rating was issued by 2 analysts: 2 Analysts recommend Atossa Genetics Inc. to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Atossa Genetics Inc. stock has an average upside potential 2026 of 756.03% register free of charge . Most analysts recommend the Atossa Genetics Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-0.20	-0.26
	16.67%	30.00%
P/E		negative

2 Analysts have issued a Atossa Genetics Inc. forecast for earnings per share. The average Atossa Genetics Inc. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-0.20	16.67%
2025	$-0.26 30.00% Unlock
2026	$-0.29 11.54% Unlock
2027	$-0.28 3.45% Unlock
2028	$0.44 257.14% Unlock
2029	$0.78 77.27% Unlock

Current	-3.17	58.45%
2025	-2.52 20.50% Unlock
2026	-2.22 11.90% Unlock
2027	-2.29 3.15% Unlock
2028	1.46 163.76% Unlock
2029	0.83 43.15% Unlock

Atossa Genetics Inc....

Current Atossa Genetics Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 26 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 12 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jan 30 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Dec 13 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Dec 12 2024
Ascendiant Capital	Locked ➜ Locked	Locked	Dec 09 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Nov 13 2024

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 26 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 12 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jan 30 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Dec 13 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Dec 12 2024
Locked Ascendiant Capital: Locked ➜ Locked	Dec 09 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Nov 13 2024

Discover more stocks with a high price target

Novo Nordisk 83.92%

Coinbase Global, Inc. 83.53%

BioNTech SE - ADR 50.09%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now